World Journal of Vaccines
Vol.7 No.2(2017), Paper ID 76623, 17
pages
DOI:10.4236/wjv.2017.72002
The Tat Protein Enhances CTL Responses and Therapeutic Immunity of Gag-Specific Exosome-Targeted T Cell-Based Gag/Tat-Texo Vaccine in Transgenic HLA-A2 Mice
Aizhang Xu, Jie Wu, Yufeng Xie, Rajni Chibbar, Andrew Fleywald, Jim Xiang
Cancer Research, Saskatchewan Cancer Agency
Department of Oncology, College of Medicine, University of Saskatchewan, Saskatchewan, Canada
Department of Oncology, The First Affiliated Hospital, Soo Chow University, Suzhou, China
Department of Pathology, College of Medicine, University of Saskatchewan, Saskatchewan, Canada
Department of Pathology, College of Medicine, University of Saskatchewan, Saskatchewan, Canada
Cancer Research, Saskatchewan Cancer Agency
Copyright © 2017 Aizhang Xu, Jie Wu, Yufeng Xie, Rajni Chibbar, Andrew Fleywald, Jim Xiang et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Xu, A. , Wu, J. , Xie, Y. , Chibbar, R. , Fleywald, A. and Xiang, J. (2017) The Tat Protein Enhances CTL Responses and Therapeutic Immunity of Gag-Specific Exosome-Targeted T Cell-Based Gag/Tat-Texo Vaccine in Transgenic HLA-A2 Mice.
World Journal of Vaccines,
7, 11-25. doi:
10.4236/wjv.2017.72002.